Literature DB >> 30807968

Understanding quit patterns from a randomized clinical trial: Latent classes, predictors, and long-term abstinence.

Lorra Garey1, Kara Manning1, Danielle E McCarthy2, Matthew W Gallagher3, Justin M Shepherd1, Michael F Orr1, Norman B Schmidt4, Blaz Rodic5, Michael J Zvolensky6.   

Abstract

OBJECTIVE: Tobacco dependence treatment is recognized as a dynamic, chronic process comprised of several specific phases. Of these phases, the Cessation phase is the most critical as it has demonstrated the strongest relation to quit success. Yet, little is understood about smoking trajectories during this period. The current study aimed to address gaps in the smoking research literature and advance understanding of the dynamic quit process unique to completing an integrated smoking treatment by evaluating quit behavior during the Cessation phase.
METHOD: Two hundred and sixty-seven treatment seeking smokers enrolled in a clinical trial to evaluate the efficacy of a novel, integrated smoking cessation treatment (46.1% male; Mage = 39.25, SD = 13.70) were included in the present study. Repeated-measure latent class analysis was employed to evaluate quit patterns from quit day through day 14 post-quit.
RESULTS: Results supported a four-class solution: Consistent Quitters, Non-Quitters, Relapsers, and Delayed Quitters. Predictors of class membership included age, number of prior quit attempts, motivation to quit smoking, and quit day smoking urges. Moreover, class membership was significantly associated with 6-month abstinence.
CONCLUSION: Results suggest that there are four relevant classes of quit behavior, each with specific predictor variables including age, motivation to quit, smoking urges, and number of quit attempts, and that these classes relate to long-term abstinence. These results have the potential to inform manualized smoking cessation treatment interventions based on relevant subgroups of quit behavior. Published by Elsevier Ltd.

Entities:  

Keywords:  Mechanism; Point prevalence abstinence; Relapse; Smoking cessation; Tobacco

Mesh:

Year:  2019        PMID: 30807968      PMCID: PMC8324080          DOI: 10.1016/j.addbeh.2019.02.018

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  38 in total

Review 1.  Shape of the relapse curve and long-term abstinence among untreated smokers.

Authors:  John R Hughes; Josue Keely; Shelly Naud
Journal:  Addiction       Date:  2004-01       Impact factor: 6.526

2.  Determinants of tobacco use and renaming the FTND to the Fagerstrom Test for Cigarette Dependence.

Authors:  Karl Fagerström
Journal:  Nicotine Tob Res       Date:  2011-10-24       Impact factor: 4.244

3.  Validation of the Avoidance and Inflexibility Scale (AIS) among treatment-seeking smokers.

Authors:  Samantha G Farris; Michael J Zvolensky; Angelo M DiBello; Norman B Schmidt
Journal:  Psychol Assess       Date:  2015-02-02

4.  Natural history of attempts to stop smoking.

Authors:  John R Hughes; Laura J Solomon; Shelly Naud; James R Fingar; John E Helzer; Peter W Callas
Journal:  Nicotine Tob Res       Date:  2014-04-09       Impact factor: 4.244

5.  Smoking-specific experiential avoidance cognition: explanatory relevance to pre- and post-cessation nicotine withdrawal, craving, and negative affect.

Authors:  Samantha G Farris; Michael J Zvolensky; Norman B Schmidt
Journal:  Addict Behav       Date:  2014-08-06       Impact factor: 3.913

6.  Reliability of the Fagerstrom Tolerance Questionnaire and the Fagerstrom Test for Nicotine Dependence.

Authors:  C S Pomerleau; S M Carton; M L Lutzke; K A Flessland; O F Pomerleau
Journal:  Addict Behav       Date:  1994 Jan-Feb       Impact factor: 3.913

7.  Tobacco withdrawal symptoms mediate motivation to reinstate smoking during abstinence.

Authors:  Claudia G Aguirre; Jillian Madrid; Adam M Leventhal
Journal:  J Abnorm Psychol       Date:  2015-08

8.  Paths to tobacco abstinence: A repeated-measures latent class analysis.

Authors:  Danielle E McCarthy; Lemma Ebssa; Katie Witkiewitz; Saul Shiffman
Journal:  J Consult Clin Psychol       Date:  2015-04-13

9.  Recurrent event analysis of lapse and recovery in a smoking cessation clinical trial using bupropion.

Authors:  E Paul Wileyto; Freda Patterson; Raymond Niaura; Leonard H Epstein; Richard A Brown; Janet Audrain-McGovern; Larry W Hawk; Caryn Lerman
Journal:  Nicotine Tob Res       Date:  2005-04       Impact factor: 4.244

10.  Process of smoking cessation. Implications for clinicians.

Authors:  J O Prochaska; M G Goldstein
Journal:  Clin Chest Med       Date:  1991-12       Impact factor: 2.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.